MAZZASCHI, GIULIA
MAZZASCHI, GIULIA
Dipartimento di Medicina e Chirurgia
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
2021-01-01 Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M.
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
2021-01-01 Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
2022-01-01 Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors
2022-01-01 Pecci, Federica; Cantini, Luca; Cognigni, Valeria; Perrone, Fabiana; Agostinelli, Veronica; Mazzaschi, Giulia; Favari, Elda; Maffezzoli, Michele; Cortellini, Alessio; Rossi, Francesca; Chiariotti, Rebecca; Venanzi, Francesco; Mentrasti, Giulia; Russo, Giuseppe Lo; Galli, Giulia; Proto, Claudia; Ganzinelli, Monica; Tronconi, Francesca; Morgese, Francesca; Campolucci, Carla; Moretti, Marco; Vignini, Arianna; Bersanelli, Melissa; Buti, Sebastiano; Berardi, Rossana
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME
2017-01-01 Quaini, Federico; Armani, G.; Madeddu, Denise; Mazzaschi, Giulia; Bocchialini, Giovanni; Sogni, Francesco; Frati, Caterina; Urbanek, KONRAD ARKADIUSZ; Lorusso, Bruno; Falco, Angela; Lagrasta, C. A.; Quaini, E.; Carbognani, P.; Ampollini, Luca
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer
2018-01-01 Armani, Giovanna; Madeddu, Denise; Mazzaschi, Giulia; Bocchialini, Giovanni; Sogni, Francesco; Frati, Caterina; Lorusso, Bruno; Falco, Angela; Lagrasta, Costanza Annamaria; Cavalli, Stefano; Mangiaracina, Chiara; Vilella, Rocchina; Becchi, Gabriella; Gnetti, Letizia; Corradini, Emilia; Quaini, Eugenio; Urbanek, Konrad; Goldoni, Matteo; Carbognani, Paolo; Ampollini, Luca; Quaini, Federico
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis
2021-01-01 Buti, Sebastiano; Bersanelli, Melissa; Mazzaschi, Giulia; Cattrini, Carlo; Brunelli, Matteo; Maio, Massimo Di
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab
2017-01-01 Tiseo, M.; Facchinetti, F.; Buti, S.; Gelsomino, F.; Veneziani, M.; Squadrilli, A.; Bordi, P.; Bersanelli, M.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Mazzaschi, G.; Leonardi, F.; Quaini, F.; Ardizzoni, A.; Missale, G.
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab
2018-01-01 Facchinetti, F.; Veneziani, M.; Buti, S.; Gelsomino, F.; Squadrilli, A.; Bordi, P.; Bersanelli, M.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Mazzaschi, G.; Leonardi, F.; Quaini, F.; Ardizzoni, A.; Missale, G.; Tiseo, M.
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
2021-01-01 Buti, S.; Perrone, F.; Zielli, T.; Mazzaschi, G.; Casartelli, C.; Leonetti, A.; Milanese, G.; Silva, M.; Eufrasia Ledda, R.; Musolino, A.; Pucci, F.; Bersanelli, M.; Tiseo, M.
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis
2020-01-01 Pellegrino, B.; Mazzaschi, G.; Madeddu, D.; Mori, C.; Lagrasta, C. A. M.; Missale, G.; Quaini, F.; Musolino, A.
Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literature
2021-01-01 Mazzaschi, G.; Quaini, F.; Bersanelli, M.; Buti, S.
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer
2020-01-01 Mazzaschi, G.; Milanese, G.; Pagano, P.; Madeddu, D.; Gnetti, L.; Trentini, F.; Falco, A.; Frati, C.; Lorusso, B.; Lagrasta, C.; Minari, R.; Ampollini, L.; Silva, M.; Sverzellati, N.; Quaini, F.; Roti, G.; Tiseo, M.
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study
2020-01-01 Minari, R.; Mazzaschi, G.; Bordi, P.; Gnetti, L.; Alberti, G.; Altimari, A.; Gruppioni, E.; Sperandi, F.; Parisi, C.; Guaitoli, G.; Bettelli, S.; Longo, L.; Bertolini, F.; Pagano, M.; Bonelli, C.; Tagliavini, E.; Nicoli, D.; Ubiali, A.; Zangrandi, A.; Trubini, S.; Proietto, M.; Fiorentino, M.; Tiseo, M.
Dynamic evaluation of circulating mirna profile in egfr‐ mutated nsclc patients treated with egfr‐tkis
2021-01-01 Leonetti, A.; Capula, M.; Minari, R.; Mazzaschi, G.; Gregori, A.; El Hassouni, B.; Papini, F.; Bordi, P.; Verze, M.; Avan, A.; Tiseo, M.; Giovannetti, E.
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens
2022-01-01 Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer
2022-01-01 Mazzaschi, G.; Moron Dalla Tor, L.; Milanese, G.; Balbi, M.; Tognazzi, D.; Lorusso, B.; Verzè, M.; Pluchino, M.; Minari, R.; Leo, L.; Ledda, R. E.; Bordi, P.; Leonetti, A.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.
2017-01-01 Fumarola, Claudia; Cretella, Daniele; LA MONICA, Silvia; Bonelli, Mara; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea
Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review
2023-01-01 Mazzaschi, Giulia; Quaini, Federico; Buti, Sebastiano
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture
2017-01-01 Mazzaschi, Giulia; Madeddu, Denise; Bocchialini, G; Gnetti, L; Armani, G; Sogni, F; Tiseo, M; Ardizzoni, A; Aversa, Franco; Quaini, Federico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy | 1-gen-2021 | Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M. | |
| 17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients | 1-gen-2021 | Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| 238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors | 1-gen-2022 | Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| 91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors | 1-gen-2022 | Pecci, Federica; Cantini, Luca; Cognigni, Valeria; Perrone, Fabiana; Agostinelli, Veronica; Mazzaschi, Giulia; Favari, Elda; Maffezzoli, Michele; Cortellini, Alessio; Rossi, Francesca; Chiariotti, Rebecca; Venanzi, Francesco; Mentrasti, Giulia; Russo, Giuseppe Lo; Galli, Giulia; Proto, Claudia; Ganzinelli, Monica; Tronconi, Francesca; Morgese, Francesca; Campolucci, Carla; Moretti, Marco; Vignini, Arianna; Bersanelli, Melissa; Buti, Sebastiano; Berardi, Rossana | |
| BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME | 1-gen-2017 | Quaini, Federico; Armani, G.; Madeddu, Denise; Mazzaschi, Giulia; Bocchialini, Giovanni; Sogni, Francesco; Frati, Caterina; Urbanek, KONRAD ARKADIUSZ; Lorusso, Bruno; Falco, Angela; Lagrasta, C. A.; Quaini, E.; Carbognani, P.; Ampollini, Luca | |
| Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer | 1-gen-2018 | Armani, Giovanna; Madeddu, Denise; Mazzaschi, Giulia; Bocchialini, Giovanni; Sogni, Francesco; Frati, Caterina; Lorusso, Bruno; Falco, Angela; Lagrasta, Costanza Annamaria; Cavalli, Stefano; Mangiaracina, Chiara; Vilella, Rocchina; Becchi, Gabriella; Gnetti, Letizia; Corradini, Emilia; Quaini, Eugenio; Urbanek, Konrad; Goldoni, Matteo; Carbognani, Paolo; Ampollini, Luca; Quaini, Federico | |
| Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis | 1-gen-2021 | Buti, Sebastiano; Bersanelli, Melissa; Mazzaschi, Giulia; Cattrini, Carlo; Brunelli, Matteo; Maio, Massimo Di | |
| Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab | 1-gen-2017 | Tiseo, M.; Facchinetti, F.; Buti, S.; Gelsomino, F.; Veneziani, M.; Squadrilli, A.; Bordi, P.; Bersanelli, M.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Mazzaschi, G.; Leonardi, F.; Quaini, F.; Ardizzoni, A.; Missale, G. | |
| Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab | 1-gen-2018 | Facchinetti, F.; Veneziani, M.; Buti, S.; Gelsomino, F.; Squadrilli, A.; Bordi, P.; Bersanelli, M.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Mazzaschi, G.; Leonardi, F.; Quaini, F.; Ardizzoni, A.; Missale, G.; Tiseo, M. | |
| Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study | 1-gen-2021 | Buti, S.; Perrone, F.; Zielli, T.; Mazzaschi, G.; Casartelli, C.; Leonetti, A.; Milanese, G.; Silva, M.; Eufrasia Ledda, R.; Musolino, A.; Pucci, F.; Bersanelli, M.; Tiseo, M. | |
| Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis | 1-gen-2020 | Pellegrino, B.; Mazzaschi, G.; Madeddu, D.; Mori, C.; Lagrasta, C. A. M.; Missale, G.; Quaini, F.; Musolino, A. | |
| Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literature | 1-gen-2021 | Mazzaschi, G.; Quaini, F.; Bersanelli, M.; Buti, S. | |
| Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer | 1-gen-2020 | Mazzaschi, G.; Milanese, G.; Pagano, P.; Madeddu, D.; Gnetti, L.; Trentini, F.; Falco, A.; Frati, C.; Lorusso, B.; Lagrasta, C.; Minari, R.; Ampollini, L.; Silva, M.; Sverzellati, N.; Quaini, F.; Roti, G.; Tiseo, M. | |
| Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study | 1-gen-2020 | Minari, R.; Mazzaschi, G.; Bordi, P.; Gnetti, L.; Alberti, G.; Altimari, A.; Gruppioni, E.; Sperandi, F.; Parisi, C.; Guaitoli, G.; Bettelli, S.; Longo, L.; Bertolini, F.; Pagano, M.; Bonelli, C.; Tagliavini, E.; Nicoli, D.; Ubiali, A.; Zangrandi, A.; Trubini, S.; Proietto, M.; Fiorentino, M.; Tiseo, M. | |
| Dynamic evaluation of circulating mirna profile in egfr‐ mutated nsclc patients treated with egfr‐tkis | 1-gen-2021 | Leonetti, A.; Capula, M.; Minari, R.; Mazzaschi, G.; Gregori, A.; El Hassouni, B.; Papini, F.; Bordi, P.; Verze, M.; Avan, A.; Tiseo, M.; Giovannetti, E. | |
| Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens | 1-gen-2022 | Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M | |
| Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer | 1-gen-2022 | Mazzaschi, G.; Moron Dalla Tor, L.; Milanese, G.; Balbi, M.; Tognazzi, D.; Lorusso, B.; Verzè, M.; Pluchino, M.; Minari, R.; Leo, L.; Ledda, R. E.; Bordi, P.; Leonetti, A.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. | 1-gen-2017 | Fumarola, Claudia; Cretella, Daniele; LA MONICA, Silvia; Bonelli, Mara; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea | |
| Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review | 1-gen-2023 | Mazzaschi, Giulia; Quaini, Federico; Buti, Sebastiano | |
| Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture | 1-gen-2017 | Mazzaschi, Giulia; Madeddu, Denise; Bocchialini, G; Gnetti, L; Armani, G; Sogni, F; Tiseo, M; Ardizzoni, A; Aversa, Franco; Quaini, Federico |